Modern Bio/Pharma Patent Prosecution Strategies
- 1:30 p.m.
This panel will discuss patent prosecution strategies for your bio/pharma innovations, including the following:
- An update on best practices for drafting and prosecuting patent applications in light of generics, biosimilars, and post-grant challenges
- The increased prevalence of inherent obviousness rejections at the USPTO
- Effective project management and communication between outside and in-house counsel
Panel Moderator: Eric K. Steffe, Director
Panelist: Paul A. Calvo, Ph.D., Director
Panelist: Marsha Rose Gillentine, Ph.D., Director
Panelist: Andy Brookes, Section Head, IP Strategy, AbbVie
Panelist: Danielle Pasqualone, Ph.D., J.D., Executive Director, Intellectual Property, Five Prime Therapeutics, Inc.